Introduction
“A novel concept in Drug Delivery – Driving innovation in the drug formulations”
Biopharmaceuticals, also known as a biologics or biologicals, differ from other pharmaceutical products, or small molecules, in that they are created using biological processes rather than being chemically synthesized. They are generally large, complex biomolecules containing a peptide-bond linked amino acid sequence (containing from about fifty up to thousands of amino acid residues). They include a wide variety of medicinal products such as vaccines, blood or blood components, somatic cells, gene therapy, tissue, recombinant therapeutic proteins, or living cells that are used as therapeutics to treat diseases. Because of their complex nature combined with the size of those molecules, it creates a challenge in delivering those other than the injectable route.
NiedlFree technologies is a disruptive technology platform transforming injectable biologics into delivery by either nasal or oral routes. Significant aspects of NiedlFree’s technology are high Bio-availability combined with three ‘C’ s – Comfort, Convenience and Compliance. Its versatility extends to include a variety of drugs with a wide range of medical applications.
Versatility of Technology
-
Both small molecules and large protein moieties
-
Molecules with high and low solubility
-
Usage of proprietary carriers to overcome permeability barriers, where needed.
